MNKD - Mannkind Corp
IEX Last Trade
6.255
-0.075 -1.199%
Share volume: 4,504,841
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.33
-0.08
-1.19%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-02-23 | 2023-05-09 | 2023-08-07 | 2023-11-07 | 2024-02-27 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 285.797 M | 293.837 M | 295.282 M | 298.137 M | 313.422 M | 320.328 M | 475.198 M | 480.879 M | |
| Current Assets | 193.476 M | 218.381 M | 234.896 M | 223.299 M | 230.233 M | 225.575 M | 373.393 M | 383.102 M | |
| Inventories | 20.573 M | 18.273 M | 21.772 M | 21.998 M | 25.290 M | 27.117 M | 28.545 M | 26.442 M | |
| Other Current Assets | 3.717 M | 11.569 M | 25.477 M | 15.445 M | 32.807 M | 35.620 M | 34.848 M | 36.019 M | |
| Short Term Investments | 3.717 M | 11.569 M | 25.477 M | 15.445 M | 32.807 M | 35.620 M | 34.848 M | 36.019 M | |
| Total Receivables | 15.030 M | 23.493 M | 16.801 M | 19.714 M | 27.789 M | 21.822 M | 14.901 M | 19.912 M | |
| Current Cash | 154.156 M | 165.046 M | 170.846 M | 166.142 M | 144.347 M | 141.016 M | 295.099 M | 300.729 M | |
| Total Non-current Assets | 92.321 M | 75.456 M | 60.386 M | 74.838 M | 83.189 M | 94.753 M | 101.805 M | 97.777 M | |
| Property Plant Equipment | 37.918 M | 41.182 M | 45.126 M | 54.837 M | 69.510 M | 80.411 M | 84.220 M | 83.620 M | |
| Other Assets | 17.507 M | 17.310 M | 9.718 M | 16.378 M | 8.353 M | 8.047 M | 7.426 M | 7.447 M | |
| Intangible Assets | 1.400 M | 1.169 M | 1.153 M | 1.133 M | 1.113 M | 1.093 M | 1.073 M | 1.053 M | |
| Goodwill | 2.900 M | 3.067 M | 2.428 M | 1.998 M | 1.931 M | 1.931 M | 1.931 M | 1.931 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 285.797 M | 293.837 M | 295.282 M | 298.137 M | 313.422 M | 320.328 M | 475.198 M | 480.879 M | |
| Total liabilities | 532.853 M | 531.514 M | 545.820 M | 553.533 M | 573.909 M | 572.107 M | 721.366 M | 710.849 M | |
| Total current liabilities | 59.564 M | 59.597 M | 67.296 M | 81.853 M | 96.966 M | 96.374 M | 104.125 M | 99.896 M | |
| Accounts Payable | 7.823 M | 9.871 M | 11.052 M | 13.889 M | 17.127 M | 16.754 M | 9.580 M | 7.149 M | |
| Other liabilities | 100.368 M | 98.749 M | 105.179 M | 110.066 M | 120.138 M | 123.832 M | 270.298 M | 268.953 M | |
| Current long term debt | 9.470 M | 9.525 M | 9.565 M | 21.293 M | 26.353 M | 29.747 M | 29.809 M | 29.872 M | |
| Long term debt | 366.993 M | 367.502 M | 368.002 M | 356.735 M | 352.159 M | 347.612 M | 343.018 M | 338.355 M | |
| Other liabilities | 100.368 M | 98.749 M | 105.179 M | 110.066 M | 120.138 M | 123.832 M | 270.298 M | 268.953 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -247.056 M | -237.677 M | -250.538 M | -255.396 M | -260.487 M | -251.779 M | -246.168 M | -229.970 M | |
| Common stock | 253.644 M | 259.300 M | 263.537 M | 263.969 M | 265.626 M | 268.732 M | 269.729 M | 270.356 M | |
| Retained earnings | -3.185 B | -3.200 B | -3.217 B | -3.227 B | -3.233 B | -3.231 B | -3.229 B | -3.219 B |